Corruption in Focus

February 2015

Herbert Smith Freehills analyses anti-corruption developments in the UAE and the possible implications of the GSK investigation. In April, 2014 a number of publications, including Bloomberg and Wall Street Journal, reported that pharmaceutical manufacturer, GlaxoSmithKline PLC ("GSK"), had launched an internal investigation into its sales and marketing practices in various Middle Eastern countries. The investigation followed whistleblower allegations that certain...

To continue reading this article, Existing users can sign in / subscribe / renew and new users are requested to register.

	Cover Story
	A CRYPTO DILEMMA
	Navigating the regulatory maze and and considerations for crypto companies.
	Digital Version

Corruption in Focus

Previous Editions